- Home
- ITOS vs MYPS Comparison
ITOS vs MYPS Comparison
Compare ITOS & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- MYPS
- Stock Information
- Founded
- ITOS 2011
- MYPS 2011
- Country
- ITOS United States
- MYPS United States
- Employees
- ITOS N/A
- MYPS N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- MYPS EDP Services
- Sector
- ITOS Health Care
- MYPS Technology
- Exchange
- ITOS Nasdaq
- MYPS Nasdaq
- Market Cap
- ITOS 270.7M
- MYPS 218.2M
- IPO Year
- ITOS 2020
- MYPS N/A
- Fundamental
- Price
- ITOS $6.51
- MYPS $1.28
- Analyst Decision
- ITOS Strong Buy
- MYPS Hold
- Analyst Count
- ITOS 3
- MYPS 6
- Target Price
- ITOS $26.00
- MYPS $2.75
- AVG Volume (30 Days)
- ITOS 413.2K
- MYPS 232.1K
- Earning Date
- ITOS 05-09-2025
- MYPS 05-05-2025
- Dividend Yield
- ITOS N/A
- MYPS N/A
- EPS Growth
- ITOS N/A
- MYPS N/A
- EPS
- ITOS N/A
- MYPS N/A
- Revenue
- ITOS $35,000,000.00
- MYPS $289,429,000.00
- Revenue This Year
- ITOS N/A
- MYPS N/A
- Revenue Next Year
- ITOS $31.74
- MYPS N/A
- P/E Ratio
- ITOS N/A
- MYPS N/A
- Revenue Growth
- ITOS 177.89
- MYPS N/A
- 52 Week Low
- ITOS $4.80
- MYPS $1.14
- 52 Week High
- ITOS $18.75
- MYPS $2.55
- Technical
- Relative Strength Index (RSI)
- ITOS 55.62
- MYPS 46.44
- Support Level
- ITOS $4.80
- MYPS $1.23
- Resistance Level
- ITOS $5.55
- MYPS $1.43
- Average True Range (ATR)
- ITOS 0.43
- MYPS 0.10
- MACD
- ITOS 0.13
- MYPS 0.01
- Stochastic Oscillator
- ITOS 97.16
- MYPS 46.43
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore, and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.